Tempus AI, Inc.
TEM
Classifica tra le azioni
#1867
Tempus AI, Inc. operates as a healthcare technology company in the United... Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Prezzo delle azioni
$64.74
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$11.35B
Variazione (1 giorno)
0.03%
Variazione (1 anno)
-29.97%
Paese
US
Scambia Tempus AI, Inc. (TEM)
Categoria
Healthcare
Numero di azioni in circolazione per Tempus AI, Inc. (TEM)
Numero di azioni in circolazione al June 2026: 179.92M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Tempus AI, Inc., il numero attuale di azioni in circolazione è 179.92M. Alla fine del December 2023, la società aveva 154.17M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Tempus AI, Inc. (TEM) dal 2019 al 2026
Azioni in circolazione alla fine di ogni anno
| Anno | Azioni in circolazione | Cambia |
|---|---|---|
| 2026 (TTM) | 179.92M | 10.98% |
| 2024 | 162.12M | 5.15% |
| 2023 | 154.17M | -9.24% |
| 2022 | 169.88M | 0.00% |
| 2021 | 169.88M | 0.00% |
| 2020 | 169.88M | 5.71% |
| 2019 | 160.71M | 0.00% |
Azioni in circolazione per aziende simili o concorrenti
| Azienda | Azioni in circolazione | Differenza | Il paese |
|---|---|---|---|
| 453.00M | 151.78% |
US
|
|
| 104.47M | -41.93% |
AU
|
|
| 205.38M | 14.15% |
US
|
|
| 129.98M | -27.75% |
US
|
|
| - | - |
US
|
